rcca-header
Clinical Trials

“An Open-Label, Single Arm Phase II Study of Nivolumab in Combination with Ipilimumab as first line-therapy in stage IV Non-Small Cell Lung Cancer (NSCLC) “

Type of Cancer
Lung
Phase
Division (Location)
Hackensack, NJ
Study ID
NCT#
Brief Description
“An Open-Label, Single Arm Phase II Study of Nivolumab in Combination with Ipilimumab as first line-therapy in stage IV Non-Small Cell Lung Cancer (NSCLC) “

To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.